Pathophysiological Basis of Hidradenitis Suppurativa
NCT06370052 · Status: NOT_YET_RECRUITING · Type: OBSERVATIONAL · Enrollment: 50
Last updated 2025-02-18
Summary
HS is a chronic inflammatory disease manifested by recurrent inflammatory nodules, abscesses and tunnels under the skin. This disease is characterized by an inflammatory process that takes place in hair follicles, sebaceous glands and surrounding tissue. Because of its frequent recurrence and chronicity, it represents a major public health problem and there is a need for better diagnosis and new and more effective drugs. This research can be a part of realizing the stated needs.
Conditions
Interventions
- PROCEDURE
-
excision
excision of the affected area
Sponsors & Collaborators
-
Clinical Hospital Center Rijeka
lead OTHER
Principal Investigators
-
Damir Juranić, MD · surgeon at CHC Rijeka
Eligibility
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2025-02-28
- Primary Completion
- 2025-12-31
- Completion
- 2026-12-31
More Related Trials
-
A Study of Zasocitinib in Adults With Hidradenitis Suppurativa
NCT07244263 ·Status: RECRUITING ·Phase: PHASE2
-
Patient's Perspective on the Evolution of Hidradenitis Suppurativa Burden After Secukinumab Initiation
NCT06444087 ·Status: ACTIVE_NOT_RECRUITING
-
Study of Single Doses of SBT777101 in Subjects With Hidradenitis Suppurativa
NCT06361836 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE1
-
A Randomized Trial Comparing the Efficacy and Safety of Secukinumab with Tofacitinib in the Treatment of Moderate to Severe Hidradenitis Suppurativa in Chinese Patients
NCT06707246 ·Status: RECRUITING ·Phase: NA
-
Real-world Secukinumab Outcomes in Canadian HS Patients
NCT07282015 ·Status: RECRUITING
-
Efficacy and Safety of SCT650C in Participants With Moderate to Severe Hidradenitis Suppurativa
NCT07244510 ·Status: RECRUITING ·Phase: PHASE2
-
Study to Evaluate Tulisokibart for Hidradenitis Suppurativa (MK-7240-012)
NCT06956235 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE2
-
Study to Compare Two Treatments for Axillary Hidradenitis Suppurativa: Carbon Dioxide Laser Versus Surgical Deroofing
NCT02163746 ·Status: COMPLETED ·Phase: NA
-
Managed Access Programs for AIN457, Secukinumab
NCT05583604 ·Status: AVAILABLE
-
The Safety and Efficacy of Roflumilast Foam in HS
NCT07263230 ·Status: RECRUITING ·Phase: PHASE2
-
Gentian Violet Treatment for Hidradenitis Suppurativa
NCT04388163 ·Status: WITHDRAWN ·Phase: PHASE2
-
Secukinumab Treatment for Moderate to Severe Hidradenitis Suppurativa
NCT07109765 ·Status: RECRUITING
-
A Study to Explore the Safety, Tolerability, Efficacy, and Pharmacokinetics of LT-002-158 Tablets in Chinese Adult Patients With Hidradenitis Suppurativa
NCT06932003 ·Status: NOT_YET_RECRUITING ·Phase: PHASE1/PHASE2
-
Validation of the French Version of the Score on Quality of Life (HiSQOL) in Hidradenitis Suppurativa (QUALIVER)
NCT05986825 ·Status: COMPLETED
-
Study of Efficacy and Safety of Two Secukinumab Dose Regimens in Subjects With Moderate to Severe Hidradenitis Suppurativa (HS)
NCT03713632 ·Status: COMPLETED ·Phase: PHASE3
-
A Study Investigating Long-term Treatment With Spesolimab in People With a Skin Disease Called Hidradenitis Suppurativa Who Completed a Previous Clinical Trial
NCT04876391 ·Status: COMPLETED ·Phase: PHASE2
-
Extension Study to Assess Effects of Non-interrupted Versus Interrupted and Long Term Treatment of Two Dose Regimes of Secukinumab in Subjects With Hidradenitis Suppurativa
NCT04179175 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE3
-
Long Term Observational Study to Collect in a Real-world populatIon Data on the Treatment Pattern of secukinumAb in Adult Patients With Moderate to Severe Hidradenitis Suppurativa.
NCT05921994 ·Status: ACTIVE_NOT_RECRUITING
-
Efficacy and Safety Study of BDB-001 Injection in Patients With Moderate to Severe Hidradenitis Suppurativa (HS)
NCT05093855 ·Status: COMPLETED ·Phase: PHASE2
-
Safety and Efficacy Study of BDB-001 Injection in Patients With Moderate to Severe Hidradenitis Suppurativa (HS)
NCT05103423 ·Status: COMPLETED ·Phase: PHASE1/PHASE2
-
Tibulizumab Skin Healing and Inflammation Evaluation for Lasting Defense
NCT06993610 ·Status: RECRUITING ·Phase: PHASE2
-
Study to Collect in a Real-world populatIon Data on the Treatment Pattern of Secukinumab in Adult Patients With Moderate to Severe Hidradenitis Suppurativa (HS) in Routine Clinical Practice in the Russian Federation
NCT06517732 ·Status: ACTIVE_NOT_RECRUITING
-
A Study to Evaluate RIST4721 in Hidradenitis Suppurativa (HS)
NCT05348681 ·Status: TERMINATED ·Phase: PHASE2
-
Brivekimig for the Treatment of Moderate to Severe Hidradenitis Suppurativa
NCT07170917 ·Status: RECRUITING ·Phase: PHASE2
-
Patient Satisfaction in Cutaneous Surgery
NCT01535963 ·Status: ACTIVE_NOT_RECRUITING